NCT00675883View on ClinicalTrials.gov

COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Multiple Sclerosis, Relapsing-Remitting
Trial Locations (1)

Unknown

University Hospital, London Health Sciences Centre, London

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT00675883 - COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS | Biotech Hunter | Biotech Hunter